Septin4, VHL, and HIF-1α in Cardiomyocyte Apoptosis
2026-09-08
The reference study identifies Septin4 as a previously unrecognized regulator of HIF-1α stability in hypoxia-exposed cardiomyocytes. Rather than acting only through its established proapoptotic partners, Septin4 enhances VHL-dependent ubiquitination and degradation of HIF-1α, thereby weakening a cardioprotective hypoxia response and increasing apoptosis.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Assay Reliability
2026-09-08
Learn how EZ Cap™ Cy5 EGFP mRNA (5-moUTP), SKU R1011, separates mRNA uptake from functional translation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide combines product specifications with published electroporation evidence to improve controls, interpretation, and day-to-day reproducibility.
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-07
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus provides an in vitro transcription workflow for producing randomly Cy3-modified RNA probes for fluorescence-based detection. It is intended for research applications such as in situ hybridization and Northern blot hybridization, not for diagnostic, clinical, therapeutic, or medical use.
Degarelix acetate: Assay Workflows and Insights
2026-09-05
Build reproducible GnRH receptor blockade assays that connect receptor binding, pituitary hormone regulation, and prostate cancer research. This guide translates a clinically relevant testosterone-bounce finding into practical sampling, controls, troubleshooting, and translational study design.
Palomid 529 (P529) for PI3K/Akt/mTOR Studies
2026-09-05
Palomid 529 (P529) is a practical dual mTORC1/mTORC2 probe for connecting pathway signaling with ESCC metastasis, cisplatin resistance, endothelial responses, and radiotherapy enhancement. This workflow-focused guide covers dosing, controls, combination designs, and troubleshooting while separating established product data from hypothesis-generating applications.
Cimetidine Beyond Acid: A BBB Assay Strategy
2026-09-04
Cimetidine is more than a histamine-2 receptor antagonist: its context-dependent pharmacology makes it a useful probe for H2 receptor signaling and cancer research. This article translates a 2025 surrogate blood-brain barrier study into practical assay decisions without assuming that in vitro permeability equals clinical brain exposure.
Wnt agonist 1: Experimental Workflow Guide
2026-09-04
Wnt agonist 1, also called BML-284, provides a practical gain-of-function tool for testing β-catenin-dependent transcription, differentiation, and developmental phenotypes. This guide connects controlled Wnt signaling pathway activation with mechanistic assays inspired by a lung cancer brain-metastasis study linking Wnt/NR2F2 signaling to GPX4 regulation and platinum resistance.
Cyanine 5-dCTP: From Labeling to Assay Design
2026-09-03
Cyanine 5-dCTP enables red-fluorescent DNA labeling, but its greatest value emerges when nucleotide chemistry, enzyme accessibility, and optical readout are designed together. This article translates DNA-framework research into practical decisions for PCR, sequencing, imaging, and nucleic acid detection.
Multiomics Dissection of Acute Liver Injury Therapies
2026-09-03
The reference study integrates co-expression modules, transcriptomics, and proteomics to compare how bifendate and muaddil sapra respond to CCl4-induced acute liver injury. Its main contribution is a systems-level view that separates shared disease modules from drug-associated regulatory and protein changes, offering a framework for mechanism-focused liver injury research.
Grazoprevir hydrate: From Protease Signal to Study Design
2026-09-02
Grazoprevir hydrate, also known as MK-5172 hydrate, is examined here through a translational lens: how NS3/4A inhibition, genotype-dependent potency, pharmacokinetics, and resistance biology should shape HCV research decisions. The article connects molecular activity with clinically relevant assay design without reducing the compound to a single EC₅₀ value.
Pioglitazone Workflows for PPARγ Research
2026-09-02
Pioglitazone is a selective PPARγ agonist for connecting receptor activation with metabolic, macrophage, and tissue-protection readouts. This workflow-oriented guide translates published DSS colitis findings into practical cell, animal, and troubleshooting strategies for reproducible inflammatory and metabolic research.
CIP2A–PKM2 Signaling Drives NSCLC Oxidative Metabolism
2026-09-01
The reference study identifies CIP2A as a metabolic regulator in non-small cell lung cancer, showing that it binds PKM2, promotes PKM2 tetramer formation, and redirects pyruvate metabolism toward mitochondrial oxidative phosphorylation. Its findings connect CIP2A, PKM2 phosphorylation at S287, mitochondrial localization, and Bcl2-dependent survival, while suggesting that combined CIP2A and glycolysis inhibition may provide a tractable experimental strategy.
Selonsertib (GS-4997) for ASK1 Kidney Research
2026-08-31
Selonsertib, also called GS-4997, is an ATP-competitive ASK1 inhibitor for research on oxidative stress, p38/JNK signaling, inflammation, and fibrosis. A 2024 lupus nephritis study reported that GS-4997 reduced renal inflammation, fibrosis, and tubulointerstitial injury in MRL/lpr mice and LPS-stimulated HK-2 cells.
Nigericin Workflows for pH and Ion-Transport Studies
2026-08-31
Nigericin provides a practical way to connect potassium/proton exchange with intracellular pH, mitochondrial stress, and cancer-cell vulnerability. This workflow-led guide shows how to prepare, dose, validate, and troubleshoot Nigericin experiments while using metabolism-focused findings from antibiotic-resistance research without overstating cross-domain evidence.
GDC-0941 for PI3K/Akt Cancer Research
2026-08-30
GDC-0941 is a practical PI3K inhibitor for connecting rapid pAKT suppression with cancer cell proliferation inhibition, apoptosis assay results, and resistance biology. This workflow translates the DRD4–Akt/β-catenin findings in liver cancer into controlled, pathway-focused experiments while preserving clear limits between published evidence and proposed assay extensions.
462 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page